ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2013

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland.

Jonas Nilsson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.